Prostate cancer is a leading cause of death among men. But each September, the Prostate Conditions Education Council (PCEC) helps patients catch the disease early during the organization’s annual Prostate Cancer Awareness Week (PCAW).
Established in an effort to encourage patients to be proactive with their prostate health, PCAW provides men across the United States with access to a number of free or low-cost health events and screenings. The PCEC recommends that men aged 40 and older use this opportunity to receive a PSA test and a digital rectal exam (DRE), both of which are considered among the safest and most reliable methods of detecting prostate cancer in its early stages.
Because there are a number of factors that can potentially contribute to a patient’s risk of prostate cancer, many screening locations also offer testing for cholesterol and testosterone. Additionally, PCAW screening sites can provide patients with informational materials and other resources to educate them on their prostate health and to help them improve their overall condition.
“What many men do not realize is that prostate cancer, if caught early, can most often be very successfully treated,” according to PCEC founder and chairman E. David Crawford, MD. “Men should not avoid the topic. Knowledge is power, and by avoiding medical tests, they are only doing a disservice to themselves and their loved ones.”
The PCEC sponsored its 26th Annual PCAW in September 2015. Following in the PCEC’s lead, several other health organizations have also organized prostate health events and screenings throughout the month of September. As of 1999, the American Foundation for Urological Disease (now the Urology Care Foundation) has designated the whole month of September as National Prostate Health Month.
“During the past 27 years, PCEC helped to provide early detection to more than 5 million men for prostate cancer and men’s health conditions in the United States and internationally,” said PCEC president Wendy Poage. “Our commitment to educating and awareness on prostate cancer and other important men’s health issues continues to expand each year.”
The 27th Annual PCAW will take place on Sept. 18 to 24, 2016. A list of screening sites can be found on the PCEC’s website.
Key Advances in Cancer Survivorship Toxicity Management
July 15th 2022In this episode of The Vitals, Lidia Schapira, MD, FASCO, recounts highlights from the 2022 ASCO Symptoms and Survivorship track and underscores key takeaways for practitioners seeking to enhance the delivery of cancer survivorship care.
Maintenance Avelumab Has Similar Efficacy in Real World for Urothelial Cancer
March 5th 2024Patients with metastatic urothelial cancer treated with frontline maintenance therapy with avelumab following platinum-based chemotherapy in the real-world setting had similar outcomes as observed in the JAVELIN Bladder 100 trial.